4//SEC Filing
Kelly Paul Edward 4
Accession 0001213900-25-106835
CIK 0001553643other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 7:30 AM ET
Size
4.6 KB
Accession
0001213900-25-106835
Insider Transaction Report
Form 4
Kelly Paul Edward
DirectorChief Operating Officer
Transactions
- Purchase
Common Stock
2025-11-05$2.20/sh+90,000$198,000→ 502,295 total
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001658544
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 7:30 AM ET
- Size
- 4.6 KB